Cargando…

Method for detection of respiratory viruses in the sputa of patients with cystic fibrosis

Since the role of respiratory viruses in lung exacerbations of patients with cystic fibrosis has been hampered by the difficulty of detecting viruses in viscous sputum specimens, a multiplex reverse transcriptase PCR (RT-PCR) assay combined with colorimetric amplicon detection was tested for the ide...

Descripción completa

Detalles Bibliográficos
Autores principales:	Punch, G., Syrmis, M. W., Rose, B. R., Harbour, C., Bye, P. T. P., Nissen, M. D., Elkins, M. R., Sloots, T. P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2004
Materias:	Concise Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7088139/ https://www.ncbi.nlm.nih.gov/pubmed/15616837 http://dx.doi.org/10.1007/s10096-004-1273-7

Ejemplares similares

Molecular Detection of Multiple Emerging Pathogens in Sputa from Cystic Fibrosis Patients
por: Bittar, Fadi, et al.
Publicado: (2008)

Disruption of Cross-Feeding Inhibits Pathogen Growth in the Sputa of Patients with Cystic Fibrosis
por: Flynn, Jeffrey M., et al.
Publicado: (2020)

The Sputa in Phthisis
Publicado: (1858)

Strong incidence of Pseudomonas aeruginosa on bacterial rrs and ITS genetic structures of cystic fibrosis sputa
por: Pages-Monteiro, Laurence, et al.
Publicado: (2017)

Cough-generated aerosols of Pseudomonas aeruginosa and other Gram-negative bacteria from patients with cystic fibrosis
por: Wainwright, C E, et al.
Publicado: (2009)

Albuminous and Non-Albuminous Sputa
Publicado: (1910)

A comparison of two informative SNP-based strategies for typing Pseudomonas aeruginosa isolates from patients with cystic fibrosis
por: Syrmis, Melanie W, et al.
Publicado: (2014)

THE SPECIFIC POLYSACCHARIDE CONTENT OF PNEUMONIC SPUTA
por: Tripp, J. T., et al.
Publicado: (1942)

Losartan ameliorates TGF-β1–induced CFTR dysfunction and improves correction by cystic fibrosis modulator therapies
por: Kim, Michael D., et al.
Publicado: (2022)

Evaluation of appropriate transmission-based precautions for non-SARS-CoV-2 respiratory viruses
por: Falk, Cassandra L., et al.
Publicado: (2023)

Feasibility of parental collected nasal swabs for virus detection in young children with cystic fibrosis
por: Gangell, C.L., et al.
Publicado: (2014)

The use of an alternate side lying positioning strategy during inhalation therapy does not prolong nebulisation time in adults with Cystic Fibrosis: a randomised crossover trial
por: Dentice, Ruth L., et al.
Publicado: (2018)

Impact of rapid Cepheid Xpert Xpress severe acute respiratory coronavirus virus 2 (SARS-CoV-2) reverse-transcription polymerase chain reaction (RT-PCR) testing in Detroit Medical Center hospitals during the coronavirus disease 2019 (COVID-19) pandemic
por: Meyer, Monica P., et al.
Publicado: (2022)

Exacerbation induces a microbiota shift in sputa of COPD patients
por: Jubinville, Eric, et al.
Publicado: (2018)

Respiratory culture nudge improves antibiotic prescribing for Moraxella catarrhalis and Haemophilus influenzae lower respiratory tract infections
por: Arena, Christen J., et al.
Publicado: (2023)

Estimating severe acute respiratory coronavirus virus 2 (SARS-CoV-2) seroprevalence from residual clinical blood samples, January–March 2021
por: Graciaa, Daniel S., et al.
Publicado: (2022)

Emerging respiratory agents: New viruses for old diseases?
por: Sloots, T.P., et al.
Publicado: (2008)

Respiratory viruses in children with cystic fibrosis: viral detection and clinical findings
por: Burns, Jane L., et al.
Publicado: (2011)

Some Additional Experiments upon the Communicability of Tuberculosis in Dogs by Means of Inhalation of Phthisical Sputa
por: Tappeiner,, et al.
Publicado: (1881)

Widespread severe acute respiratory coronavirus virus 2 (SARS-CoV-2) laboratory surveillance program to minimize asymptomatic transmission in high-risk inpatient and congregate living settings
por: Jatt, Lauren P., et al.
Publicado: (2020)

Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) screening among symptom-free healthcare workers
por: Demmer, Ryan T., et al.
Publicado: (2021)

Antibodies in healthcare personnel following severe acute respiratory syndrome coronavirus virus 2 (SARS-CoV-2) infection
por: Bosserman, Rachel E., et al.
Publicado: (2022)

Continuously active disinfectant inactivates severe acute respiratory coronavirus virus 2 (SARS-CoV-2) and human coronavirus 229E two days after the disinfectant was applied and following wear exposures
por: Rutala, William A., et al.
Publicado: (2021)

Estimating the predictive value of negative severe acute respiratory coronavirus virus 2 (SARS-CoV-2) results: A prospective study
por: Hirschwerk, David, et al.
Publicado: (2020)

Air exchanges, climate change, and severe acute respiratory coronavirus virus 2 (SARS-CoV-2): Results from a survey of the Society of Healthcare Epidemiology of America Research Network (SRN)
por: Burnham, Jason P., et al.
Publicado: (2022)

The role of respiratory viruses in cystic fibrosis
por: Wat, Dennis, et al.
Publicado: (2008)

Side lying during nebulisation can significantly improve apical deposition in healthy adults and adults with mild cystic fibrosis lung disease: a randomised crossover trial
por: Dentice, Ruth L., et al.
Publicado: (2019)

Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infections occurring in healthcare workers after booster vaccination: A comparison of delta versus omicron variants
por: Reeves, Kimberly D., et al.
Publicado: (2022)

Cell‐based therapy to reduce mortality from COVID‐19: Systematic review and meta‐analysis of human studies on acute respiratory distress syndrome
por: Qu, Wenchun, et al.
Publicado: (2020)

Sensitivity of midturbinate versus nasopharyngeal swabs for the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
por: Jamal, Alainna J., et al.
Publicado: (2020)

Seroprevalence of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) antibodies among healthcare workers with differing levels of coronavirus disease 2019 (COVID-19) patient exposure
por: Hunter, Benton R., et al.
Publicado: (2020)

Impact of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) vaccination on the incidence of coronavirus disease 2019 (COVID-19) among healthcare workers at an academic medical center in Vermont
por: Noyes, Cindy D., et al.
Publicado: (2022)

The long-term sustainability of a respiratory culture nudge
por: Kaur, Supreet, et al.
Publicado: (2022)

Absence of nosocomial influenza and respiratory syncytial virus infection in the coronavirus disease 2019 (COVID-19) era: Implication of universal masking in hospitals
por: Wong, Shuk-Ching, et al.
Publicado: (2020)

Assessing severe acute respiratory coronavirus virus 2 (SARS-CoV-2) preparedness in US community hospitals: A forgotten entity
por: Advani, Sonali D., et al.
Publicado: (2020)

Global population-level association between herpes simplex virus 2 prevalence and HIV prevalence
por: Kouyoumjian, Silva P., et al.
Publicado: (2018)

Pathological and Clinical Observations on the Fœtid Grains or Tubercles, Mixed with the Sputa of Consumptive Persons
por: Ballhorn,
Publicado: (1806)

Large-scale screening for severe acute respiratory coronavirus virus 2 (SARS-CoV-2) among healthcare workers: Prevalence and risk factors for asymptomatic and pauci-symptomatic carriers, with emphasis on the use of personal protective equipment (PPE)
por: Rajme-López, Sandra, et al.
Publicado: (2021)

Air contamination of households versus hospital inpatient rooms occupied by severe acute respiratory coronavirus virus 2 (SARS-CoV-2)–positive patients
por: Munoz-Price, L. Silvia, et al.
Publicado: (2021)

Impact of on-site compared to off-site testing for severe acute respiratory coronavirus virus 2 (SARS-CoV-2) on duration of isolation and resource utilization
por: Roberts, Andrew T., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jguepbprl4csi4s7quk9q5mduk